12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Company News  |  Deals

Progenics, Protein Design Labs deal

PDLI will humanize PGNX's PRO 140 anti- CCR5 monoclonal antibody that blocks...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >